Adam Smith retweetet

Incannex ( $IXHL #Nasdaq ) Finishes Phase 2 Dosing for Sleep Apnea Drug, up 721%
Topline results set for July as company gears up for pivotal #FDA meeting and Phase 3 Clinical Trial. #sleepapnea
stocksurge.com.au/incannex-ixhl-…
English























